Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

319
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
319
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

345
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
345
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

701
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
701
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

415
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
415
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

982
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
982
Measurement of Bioavailability: Pharmacokinetic Methods01:30

Measurement of Bioavailability: Pharmacokinetic Methods

469
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
469

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ssNetShift: single-sample metabolic network rewiring reveals hidden prognostic subtypes beyond clinical staging in gastric cancer.

Briefings in bioinformatics·2026
Same author

Local Sample Cohesion Normalization: Preserving Inherent Biological Heterogeneity in Metabolomics Data.

Analytical chemistry·2025
Same author

Exhausted CD8 <sup>+</sup> T Cell in HIV Infection Exhibits an Impaired Bioenergetic Metabolism Driven by Mitochondrial Dysfunction.

Immunology·2025
Same author

Local neighbor Normalization: Reconciling accurate normalization and heterogeneity recovery in large-scale metabolomics.

Analytica chimica acta·2025
Same author

Multiscale Synergy Networks Offer Insights into Disease and Comorbidity Mechanisms.

Analytical chemistry·2025
Same author

Evaluation of methoxyflavones as dengue NS2B-NS3 protease inhibitors: an in silico and in vitro studies.

Molecular diversity·2025

Related Experiment Video

Updated: Apr 16, 2026

A Strategy for Sensitive, Large Scale Quantitative Metabolomics
14:18

A Strategy for Sensitive, Large Scale Quantitative Metabolomics

Published on: May 27, 2014

21.9K

[A novel metabolomic data scaling method based on K-L divergence].

Ling-Li Deng, Kian-Kai Cheng, Gui-Ping Shen

    Guang Pu Xue Yu Guang Pu Fen Xi = Guang Pu
    |March 6, 2015
    PubMed
    Summary

    A novel Kullback-Leibler (K-L) divergence scaling method enhances NMR metabolomic data analysis. This supervised method improves noise reduction and highlights important biological variables for better interpretation and prediction.

    More Related Videos

    Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
    07:11

    Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

    Published on: November 10, 2023

    3.5K
    Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
    11:02

    Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

    Published on: November 29, 2024

    1.4K

    Related Experiment Videos

    Last Updated: Apr 16, 2026

    A Strategy for Sensitive, Large Scale Quantitative Metabolomics
    14:18

    A Strategy for Sensitive, Large Scale Quantitative Metabolomics

    Published on: May 27, 2014

    21.9K
    Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
    07:11

    Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

    Published on: November 10, 2023

    3.5K
    Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
    11:02

    Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

    Published on: November 29, 2024

    1.4K

    Area of Science:

    • Metabolomics
    • Bioinformatics
    • Analytical Chemistry

    Background:

    • NMR metabolomics generates complex datasets requiring robust preprocessing.
    • Existing scaling methods may not optimally handle non-Gaussian distributions or effectively differentiate biological signals from noise.
    • Supervised methods can improve data analysis by incorporating group information.

    Purpose of the Study:

    • To introduce a new supervised scaling method for NMR metabolomic data based on Kullback-Leibler (K-L) divergence.
    • To evaluate the efficacy of K-L scaling in noise reduction, variable weighting, and enhancing multivariate model performance.
    • To assess the method's ability to improve interpretability and facilitate the identification of metabolic signatures.

    Main Methods:

    • Development of K-L scaling, a supervised method incorporating group information.
    • Standardization of variables to unit variance followed by variance adjustment using K-L divergence.
    • Application of K-L scaling to a human urine H-NMR metabolomic dataset.
    • Comparison of K-L scaling with other methods in multivariate analysis (PCR, PLS-DA).

    Main Results:

    • K-L scaling effectively suppresses noise in multivariate models of NMR metabolomic data.
    • The method enhances the weights of biologically relevant variables while reducing the influence of noise.
    • Improved interpretability and predictability of Principal Component Regression (PCR) and Partial Least Squares Discriminant Analysis (PLS-DA) models were observed.
    • Facilitation of metabolic signature identification was demonstrated.

    Conclusions:

    • K-L scaling is an efficient supervised method for preprocessing NMR metabolomic data.
    • The method offers advantages in noise reduction and highlighting significant biological variables.
    • K-L scaling shows potential as a valuable alternative for NMR metabolomic data analysis, improving model performance and interpretability.